Pitfalls and precautions around high bribery risk jurisdictions

How to do business in red flag states

The UK Bribery Act could put private equity firms at risk

UK pharmaceutical group GlaxoSmithKline (GSK) has admitted that it is looking into allegations of bribery in Poland, Iraq, Jordan and Lebanon. These admissions come only months after the company became embroiled in a bribery scandal in China, where it was accused of funnelling as much as £320 million to doctors and government officials to boost sales. The unique point about the GSK incident is that it is the first (announced) investigation into a major corporate where alleged corrupt practices t

To continue reading...

You must be signed in to use this feature.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: